← Leaderboards
Mortimer Poncz
University Of Pennsylvania
$48,626,684
Attributed
$52,224,971
Total exposure
31
Grants
25
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$71,168,204 · 34
By mechanism
P01$33,796,658 · 14
R01$11,457,677 · 6
U01$8,582,921 · 1
R35$6,314,818 · 1
P30$4,221,647 · 2
T32$4,095,298 · 1
Top collaborators
- Deborah Lynn French5 shared
- Paul J Gadue5 shared
- Stella T Chou4 shared
- Douglas Brock Cines4 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Joel S. Bennett$17,907,964
- Scott L Diamond$29,536,327
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseBlood PlateletsIn VitroCellsIn VivoThrombosisAntibodiesAffectThrombocytopeniaProgramsClinically RelevantSiteHeparinInsightInjuryHemorrhagePlatelet Factor 4MegakaryocytesBiologyInhibitor/AntagonistBlood VesselsNovel StrategiesPlatelet ActivationThrombus
Grant awards (141)
New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets$1,056,000
R35 · FY2025 · HL · contact PI
The Immunobiology of Vaccine-induced Immune Thrombotic Thrombocytopenia$633,990
P01 · FY2025 · HL · contact PI
Pediatric Hematology Research Training Program$521,491
T32 · FY2025 · HL · contact PI
RepSox and its analog for prophylactic intervention in RUNX1 haploinsufficiency FPDMM$489,500
R21 · FY2025 · TR · contact PI
New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets$1,034,880
R35 · FY2024 · HL · contact PI
The Immunobiology of Vaccine-induced Immune Thrombotic Thrombocytopenia$650,240
P01 · FY2024 · HL · contact PI
Platelet Factor 4 and heparins in NETosis and Sepsis$577,254
P01 · FY2024 · HL · contact PI
Pediatric Hematology Research Training Program$542,971
T32 · FY2024 · HL · contact PI
New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets$1,056,000
R35 · FY2023 · HL · contact PI
Platelet Factor 4 and heparins in NETosis and Sepsis$588,882
P01 · FY2023 · HL · contact PI
Pediatric Hematology Research Training Program$448,251
T32 · FY2023 · HL · contact PI
Mechanistic and Therapeutic Studies using a Xenotransplanted RUNX1-Haploinsufficient Murine Model$178,000
R03 · FY2023 · TR · contact PI
New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets$1,056,000
R35 · FY2022 · HL · contact PI
Platelet Factor 4 and heparins in NETosis and Sepsis$590,776
P01 · FY2022 · HL · contact PI
Pediatric Hematology Research Training Program$495,013
T32 · FY2022 · HL · contact PI
New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets$1,055,938
R35 · FY2021 · HL · contact PI
Platelet Factor 4 and heparins in NETosis and Sepsis$592,483
P01 · FY2021 · HL · contact PI
Structure-based Design of Rational PF4 Inhibitors in HIT$564,008
R01 · FY2021 · HL
Pediatric Hematology Research Training Program$195,981
T32 · FY2021 · HL · contact PI
New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets$1,056,000
R35 · FY2020 · HL · contact PI
Platelet Factor 4 and heparins in NETosis and Sepsis$606,000
P01 · FY2020 · HL · contact PI
Structure-based Design of Rational PF4 Inhibitors in HIT$572,191
R01 · FY2020 · HL
Pediatric Hematology Research Training Program$323,921
T32 · FY2020 · HL · contact PI
Role of the Endothelium and Neutrophils in the Prothrombotic Nature of HIT$237,540
R01 · FY2020 · HL · contact PI
Biology and Application of Platelet-Delivered Factor VIII$584,934
R01 · FY2019 · HL · contact PI
Role of the Endothelium and Neutrophils in the Prothrombotic Nature of HIT$570,104
R01 · FY2019 · HL · contact PI
Structure-based Design of Rational PF4 Inhibitors in HIT$563,808
R01 · FY2019 · HL
Pediatric Hematology Research Training Program$307,937
T32 · FY2019 · HL · contact PI
Role of the Endothelium and Neutrophils in the Prothrombotic Nature of HIT$588,104
R01 · FY2018 · HL · contact PI
Structure-based Design of Rational PF4 Inhibitors in HIT$587,000
R01 · FY2018 · HL
Biology and Application of Platelet-Delivered Factor VIII$584,934
R01 · FY2018 · HL · contact PI
Optimization of Ex Vivo- and In Vivo- Generated Platelets$489,000
R01 · FY2018 · HL · contact PI
Platelet-Targeted Pro-urokinase for Thrombolysis$414,894
P01 · FY2018 · HL · contact PI
Pediatric Hematology Research Training Program$296,826
T32 · FY2018 · HL · contact PI
Biology and Application of Platelet-Delivered Factor VIII$584,934
R01 · FY2017 · HL · contact PI
Optimization of Ex Vivo- and In Vivo- Generated Platelets$489,000
R01 · FY2017 · HL · contact PI
Platelet-Targeted Pro-urokinase for Thrombolysis$422,756
P01 · FY2017 · HL · contact PI
Pediatric Hematology Research Training Program$287,736
T32 · FY2017 · HL · contact PI
Optimization of Ex Vivo- and In Vivo- Generated Platelets$203,381
R01 · FY2017 · HL · contact PI
Pediatric Hematology Research Training Program$727
T32 · FY2017 · HL · contact PI
Pathogenesis and management of heparin-induced thrombocytopeneia$2,253,619
P01 · FY2016 · HL · contact PI
Biology and Application of Platelet-Delivered Factor VIII$584,934
R01 · FY2016 · HL · contact PI
Optimization of Ex Vivo- and In Vivo- Generated Platelets$489,000
R01 · FY2016 · HL · contact PI
Platelet-Targeted Pro-urokinase for Thrombolysis$430,392
P01 · FY2016 · HL · contact PI
Pediatric Hematology Research Training Program$198,708
T32 · FY2016 · HL · contact PI
Administrative Core$174,082
P01 · FY2016 · HL · contact PI
Administrative Core$161,384
P01 · FY2016 · HL · contact PI
Pathogenesis and management of heparin-induced thrombocytopeneia$2,278,033
P01 · FY2015 · HL · contact PI
Gene Therapy for Hemophilia$2,046,831
P01 · FY2015 · HL · contact PI
Embryonic Stem Cell-Derived Platelets as Cellular Therapeutics$1,203,092
U01 · FY2015 · HL · contact PI
Optimization of Ex Vivo- and In Vivo- Generated Platelets$506,000
R01 · FY2015 · HL · contact PI
Platelet Factor 8 As A Novel Therapy for Hemophilia A$450,035
P01 · FY2015 · HL · contact PI
Platelet-Targeted Pro-urokinase for Thrombolysis$431,277
P01 · FY2015 · HL · contact PI
Pediatric Hematology Research Training Program$265,032
T32 · FY2015 · HL · contact PI
Cellular Events Underlying the Thrombocytopenia and Thrombosis in HIT$219,655
P01 · FY2015 · HL · contact PI
Cellular Events Underlying the Thrombocytopenia and Thrombosis in HIT$207,091
P01 · FY2015 · HL · contact PI
Human Hematopoietic Stem Cell Center of Excellence$205,548
P30 · FY2015 · DK · contact PI
Pathogenesis and management of heparin-induced thrombocytopeneia$56,785
P01 · FY2015 · HL · contact PI
Administrative Core$26,598
P01 · FY2015 · HL · contact PI
Administrative Core$25,157
P01 · FY2015 · HL · contact PI
Pathogenesis and management of heparin-induced thrombocytopeneia$2,187,355
P01 · FY2014 · HL · contact PI
Gene Therapy for Hemophilia$2,026,513
P01 · FY2014 · HL · contact PI
Embryonic Stem Cell-Derived Platelets as Cellular Therapeutics$1,266,361
U01 · FY2014 · HL · contact PI
Human Hematopoietic Stem Cell Center of Excellence$1,084,661
P30 · FY2014 · DK · contact PI
Platelet-Targeted Pro-urokinase for Thrombolysis$474,875
P01 · FY2014 · HL · contact PI
Platelet Factor 8 As A Novel Therapy for Hemophilia A$445,958
P01 · FY2014 · HL · contact PI
Pediatric Hematology Research Training Program$210,704
T32 · FY2014 · HL · contact PI
Cellular Events Underlying the Thrombocytopenia and Thrombosis in HIT$197,424
P01 · FY2014 · HL · contact PI
Cellular Events Underlying the Thrombocytopenia and Thrombosis in HIT$197,421
P01 · FY2014 · HL · contact PI
Administrative Core for Gene Therapy of Hemophilia$174,236
P01 · FY2014 · HL · contact PI
Research Base$123,719
P30 · FY2014 · DK · contact PI
Administrative Core$31,655
P01 · FY2014 · HL · contact PI
Administrative Core$31,651
P01 · FY2014 · HL · contact PI
Pathogenesis and management of heparin-induced thrombocytopeneia$2,183,320
P01 · FY2013 · HL · contact PI
Embryonic Stem Cell-Derived Platelets as Cellular Therapeutics$1,162,785
U01 · FY2013 · HL · contact PI
Platelet Factor 8 As A Novel Therapy for Hemophilia A$430,517
P01 · FY2013 · HL · contact PI
Cellular Events Underlying the Thrombocytopenia and Thrombosis in HIT$196,769
P01 · FY2013 · HL · contact PI
Cellular Events Underlying the Thrombocytopenia and Thrombosis in HIT$196,765
P01 · FY2013 · HL · contact PI
Research Base$169,273
P30 · FY2013 · DK · contact PI
Embryonic Stem Cell-Derived Platelets as Cellular Therapeutics$65,032
U01 · FY2013 · HL · contact PI
Pathogenesis and management of heparin-induced thrombocytopeneia$40,053
P01 · FY2013 · HL · contact PI
Administrative Core$31,644
P01 · FY2013 · HL · contact PI
Administrative Core$31,642
P01 · FY2013 · HL · contact PI
Pathogenesis and management of heparin-induced thrombocytopeneia$2,378,672
P01 · FY2012 · HL · contact PI
Embryonic Stem Cell-Derived Platelets as Cellular Therapeutics$1,221,413
U01 · FY2012 · HL · contact PI
Platelet Factor 8 As A Novel Therapy for Hemophilia A$450,252
P01 · FY2012 · HL · contact PI
A Negative Paracrine Loop in Megakaryopoiesis$377,154
P01 · FY2012 · HL · contact PI
Cellular Events Underlying the Thrombocytopenia and Thrombosis in HIT$339,811
P01 · FY2012 · HL · contact PI
Cellular Events Underlying the Thrombocytopenia and Thrombosis in HIT$339,811
P01 · FY2012 · HL · contact PI
Administrative Core$339,810
P01 · FY2012 · HL · contact PI
Administrative Core$339,810
P01 · FY2012 · HL · contact PI
Research Base$123,719
P30 · FY2012 · DK · contact PI
Embryonic Stem Cell-Derived Platelets as Cellular Therapeutics$1,221,413
U01 · FY2011 · HL · contact PI
Human Hematopoietic Stem Cell Center of Excellence$1,084,661
P30 · FY2011 · DK · contact PI
Etiologic and therapeutic studies of heparin-induced thrombocytopenia (HIT)$445,582
R01 · FY2011 · HL · contact PI
A Negative Paracrine Loop in Megakaryopoiesis$377,154
P01 · FY2011 · HL · contact PI
Platelet Factor 8 As A Novel Therapy for Hemophilia A$371,335
P01 · FY2011 · HL · contact PI
Research Base$130,415
P30 · FY2011 · DK · contact PI
Human Hematopoietic Stem Cell Center of Excellence$32,521
P30 · FY2011 · DK · contact PI
2011 GRC & GRS on Cell Biology of Megakaryocytes and Platelets$10,000
R13 · FY2011 · HL · contact PI
Embryonic Stem Cell-Derived Platelets as Cellular Therapeutics$1,209,075
U01 · FY2010 · HL · contact PI
Human Hematopoietic Stem Cell Center of Excellence$1,084,661
P30 · FY2010 · DK · contact PI
Etiologic and therapeutic studies of heparin-induced thrombocytopenia (HIT)$449,071
R01 · FY2010 · HL · contact PI
A Negative Paracrine Loop in Megakaryopoiesis$377,154
P01 · FY2010 · HL · contact PI
Research Base$182,469
P30 · FY2010 · DK · contact PI
Embryonic Stem Cell-Derived Platelets as Cellular Therapeutics$1,233,750
U01 · FY2009 · HL · contact PI
Ectopic F.VIII Expression in Megakaryocytes: Treatment of Hemophilia A$515,067
P01 · FY2009 · HL · contact PI
Etiologic and therapeutic studies of heparin-induced thrombocytopenia (HIT)$448,497
R01 · FY2009 · HL · contact PI
Megakaryocyte Chemokines & Post-Irradiation Thrombocytopenia$420,000
RC1 · FY2009 · AI · contact PI
A Negative Paracrine Loop in Megakaryopoiesis$377,154
P01 · FY2009 · HL · contact PI
Non-donor-Dependent Production of Wildtype and Modified Platelets$41,125
R03 · FY2009 · HL · contact PI
Etiologic and therapeutic studies of heparin-induced thrombocytopenia (HIT)$20,661
R01 · FY2009 · HL · contact PI
Ectopic F.VIII Expression in Megakaryocytes: Treatment of Hemophilia A$493,330
P01 · FY2008 · HL · contact PI
Etiologic and therapeutic studies of heparin-induced thrombocytopenia (HIT)$439,491
R01 · FY2008 · HL · contact PI
A Negative Paracrine Loop in Megakaryopoiesis$391,816
P01 · FY2008 · HL · contact PI
Ectopic F.VIII Expression in Megakaryocytes: Treatment of Hemophilia A$491,500
P01 · FY2007 · HL · contact PI
Etiologic and therapeutic studies of heparin-induced thrombocytopenia (HIT)$455,511
R01 · FY2007 · HL · contact PI
Molecular Biology of the Platelet alpha IIb/beta3 Receptor$372,565
P01 · FY2007 · HL · contact PI
Ectopic F.VIII Expression in Megakaryocytes: Treatment of Hemophilia A$475,326
P01 · FY2006 · HL · contact PI
Ectopic F.VIII Expression in Megakaryocytes: Treatment of Hemophilia A$462,028
P01 · FY2005 · HL
MOLECULAR BIOLOGY OF HEPARIN ASSOCIATED THROMBOCYTOPENIA$438,841
P50 · FY2005 · HL
MOLECULAR BIOLOGY OF HEPARIN ASSOCIATED THROMBOCYTOPENIA$427,268
P50 · FY2004 · HL
Ectopic gene expression of FVIII in megakaryocytes$312,285
P01 · FY2004 · HL
MOLECULAR BASIS OF HEPARIN-ASSOCIATED THROMBOCYTOPENIA$256,620
R01 · FY2004 · HL
Fluorescent Microscope for Thrombosis Studies$340,837
S10 · FY2003 · RR
MOLECULAR BASIS OF HEPARIN-ASSOCIATED THROMBOCYTOPENIA$249,144
R01 · FY2003 · HL
Molecular Biology of the alpha IIb/betaPlatelet Receptor$229,868
P01 · FY2003 · HL
MOLECULAR BASIS OF HEPARIN-ASSOCIATED THROMBOCYTOPENIA$241,886
R01 · FY2002 · HL
MOLECULAR BIOLOGY OF PLATELET ALPHAIIB-BETA3 RECEPTOR$197,196
P01 · FY2002 · HL
MOLECULAR BIOLOGY OF HEPARIN ASSOCIATED THROMBOCYTOPENIA$0
P50 · FY2002 · HL
Ectopic gene expression of FVIII in megakaryocytes$0
P01 · FY2002 · HL
Ectopic gene expression of FVIII in megakaryocytes$380,508
P01 · FY2001 · HL
MOLECULAR BASIS OF HEPARIN-ASSOCIATED THROMBOCYTOPENIA$252,342
R01 · FY2001 · HL
MOLECULAR BIOLOGY OF PLATELET ALPHAIIB-BETA3 RECEPTOR$197,196
P01 · FY2001 · HL
SHORT-TERM TRAINING IN THE HEALTH PROFESSIONS$41,567
T35 · FY2001 · HD
Short-term Training for Minority Students$34,965
T35 · FY2001 · HL
MOLECULAR BIOLOGY OF HEPARIN ASSOCIATED THROMBOCYTOPENIA$0
P50 · FY2001 · HL
Ectopic gene expression of FVIII in megakaryocytes$0
P01 · FY2001 · HL
MOLECULAR BIOLOGY OF PLATELET ALPHAIIB-BETA3 RECEPTOR$306,320
P01 · FY2000 · HL
MOLECULAR BIOLOGY OF HEPARIN ASSOCIATED THROMBOCYTOPENIA$277,082
P50 · FY2000 · HL
Ectopic gene expression of FVIII in megakaryocytes$187,524
P01 · FY2000 · HL